Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L8OP
|
||||
Former ID |
DIB015081
|
||||
Drug Name |
AVP-21D9
|
||||
Synonyms |
Thravixa; AVP-1C6; AVP-22G12; AVP-8C1; Anthrax antibody, AVANIR; Anthrax toxin Mab, Xenerex; Protective antigen-targeting human monoclonal antibodies (intravenous, anthrax), AVANIR; Protective antigen-targeting human monoclonal antibodies (intravenous, anthrax), Emergent
|
||||
Drug Type |
Antibody
|
||||
Indication | Bacillus anthracis infection [ICD10:A22] | Phase 1 | [523172] | ||
Company |
Emergent biosolutions
|
||||
Target and Pathway | |||||
Target(s) | Protective antigen | Target Info | [544420] | ||
Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.